BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	11,095	11,428	12,539	18,185	19,275	16,249
Market Cap Growth	2.12%	-8.86%	-31.05%	-5.66%	18.63%	1.96%
Enterprise Value	10,244	10,465	11,996	18,198	19,067	16,314
Last Close Price	57.40	59.43	65.73	96.42	103.49	88.35
PE Ratio	41.00	33.02	29.74	110.83	137.99	-
Forward PE	10.16	12.37	17.86	38.98	39.00	85.79
PEG Ratio	0.35	0.65	0.72	1.07	0.86	2.66
PS Ratio	3.40	3.55	4.39	7.52	9.20	8.80
PB Ratio	1.76	1.88	2.22	3.67	4.19	3.81
P/TBV Ratio	1.92	2.07	2.48	4.14	4.81	4.39
P/FCF Ratio	14.38	15.76	25.72	290.64	350.82	77.76
P/OCF Ratio	12.61	13.80	21.89	114.18	109.58	53.36
EV/Sales Ratio	3.16	3.25	4.20	7.52	9.10	8.84
EV/EBITDA Ratio	16.23	21.40	20.66	62.72	72.51	634.83
EV/EBIT Ratio	18.14	25.56	24.77	97.96	118.45	-
EV/FCF Ratio	13.35	14.44	24.61	290.85	347.03	78.07
Debt / Equity Ratio	0.23	0.10	0.11	0.22	0.24	0.25
Debt / EBITDA Ratio	3.68	1.22	1.02	3.75	4.12	41.99
Debt / FCF Ratio	1.87	0.82	1.22	17.37	19.71	5.16
Net Debt / Equity Ratio	-0.13	-0.16	-0.10	0.00	-0.04	0.02
Net Debt / EBITDA Ratio	-2.04	-1.97	-0.93	0.05	-0.79	2.54
Net Debt / FCF Ratio	-1.03	-1.33	-1.11	0.21	-3.79	0.31
Asset Turnover	0.40	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	0.59	0.57	0.50	0.53	0.60	0.64
Quick Ratio	3.94	3.25	2.96	1.45	2.98	2.54
Current Ratio	5.81	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	4.37%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	2.71%	4.06%	5.52%	2.50%	2.46%	-1.18%
Return on Invested Capital (ROIC)	4.05%	5.63%	7.39%	3.44%	3.38%	-1.59%
Return on Capital Employed (ROCE)	4.31%	6.20%	8.04%	3.24%	2.86%	-1.52%
Earnings Yield	2.44%	3.03%	3.36%	0.90%	0.72%	-
FCF Yield	6.96%	6.34%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	-0.86%	-0.35%	-2.67%	-1.39%	-3.34%	4.60%
Total Shareholder Return	-0.86%	-0.35%	-2.67%	-1.39%	-3.34%	4.60%

SEC Filings: 10-K · 10-Q